Fig. 6From: A cuproptosis score model and prognostic score model can evaluate clinical characteristics and immune microenvironment in NSCLCClinical characteristics and immune correlation analysis of the cuproptosis score model. (A) Immune infiltration correlation analysis network; (B) Representative image of HE staining from the TCGA database showing the immune cell infiltration in the two high-score cuproptosis groups from TCGA; (C) Immunotherapy efficacy score in the two groups. (*P < 0.05; ** P < 0.01; and *** P < 0.001; Ns, not significant). TCGA, The Cancer Genome Atlas; HE, hematoxylin and eosinBack to article page